Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Int J Cancer ; 122(3): 681-8, 2008 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-17943718

RESUMO

Skeletal metastases are a major source of morbidity for cancer patients. The purpose of this study was to evaluate the effects of megavoltage irradiation and antiangiogenic therapy on metastatic bone cancer. A tumor xenograft model was prepared in C3H/Scid mice using 4T1 murine breast carcinoma cells. Twenty-eight mice bearing tumors were treated with either bevacizumab (15 mg/kg), local megavoltage irradiation (30 Gy in 1 fraction), combination of bevacizumab and local megavoltage irradiation or physiologic saline solution (control group). Tumor area, bone destruction, tumor microvessel density, pain-associated behaviors and expression of substance P were assessed. Combined modality treatment reduced the frequency of pain-associated behaviors, decreased levels of nociceptive protein expression in the spinal cord, maintained cortical integrity and decreased the density of microvessels as compared to single modality treatments. We conclude that concurrent antiangiogenic therapy and localized radiotherapy for the treatment of bone metastases warrants further evaluation in human clinical trials.


Assuntos
Inibidores da Angiogênese/uso terapêutico , Anticorpos Monoclonais/uso terapêutico , Neoplasias Ósseas/secundário , Neoplasias Ósseas/terapia , Osso e Ossos/efeitos da radiação , Modelos Animais de Doenças , Dor/radioterapia , Animais , Anticorpos Monoclonais Humanizados , Bevacizumab , Neoplasias Ósseas/tratamento farmacológico , Neoplasias Ósseas/radioterapia , Osso e Ossos/patologia , Terapia Combinada , Feminino , Neoplasias Mamárias Experimentais/patologia , Neoplasias Mamárias Experimentais/terapia , Camundongos , Camundongos Endogâmicos C3H , Camundongos SCID , Dor/etiologia
2.
J Pharm Pharmacol ; 64(12): 1709-14, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23146033

RESUMO

OBJECTIVES: Intranasal delivery has been shown to target peptide therapeutics to the central nervous system (CNS) of animal models and induce specific neurological responses. In an investigation into the pathways by which intranasal administration delivers insulin to the CNS, this study has focused on the direct delivery of insulin from the olfactory mucosa to the olfactory bulbs via the olfactory nerve pathway. METHODS: Nasal and olfactory tissues of mice were imaged with fluorescent and electron microscopy 30 min following intranasal administration. KEY FINDINGS: Macroscopic analysis confirmed delivery to the anterior regions of the olfactory bulbs. Confocal microscopy captured delivery along the olfactory nerve bundles exiting the nasal mucosa, traversing the cribriform plate and entering the bulbs. With electron microscopy, insulin was found within cells of the olfactory nerve layer and glomerular layer of the olfactory bulbs. CONCLUSIONS: These results demonstrated that intranasal administration of labelled insulin targeted the CNS through the olfactory nerve pathway in mice.


Assuntos
Administração Intranasal , Insulina/administração & dosagem , Mucosa Nasal/metabolismo , Nervo Olfatório/metabolismo , Condutos Olfatórios/metabolismo , Animais , Sistema Nervoso Central/metabolismo , Osso Etmoide/metabolismo , Insulina/metabolismo , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Microscopia/métodos , Bulbo Olfatório/metabolismo
3.
Eur J Cancer ; 44(16): 2506-17, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18723339

RESUMO

The receptor tyrosine kinase inhibitor, SU11248, was added to localised radiation to evaluate the response of bone metastases and to define the basic mechanism of radiosensitisation. Treatment with SU11248 and radiation was assessed in vitro using cultured 4T1 breast cancer cells and in vivo using an orthotopic 4T1 murine mammary tumour model of breast cancer bone metastasis. Cultured 4T1 cells treated with SU11248 (1 microM) and radiation (10 Gy) showed an almost 7.5-fold increase in caspase-mediated apoptosis after 24 h of incubation, compared to either treatment alone. Mice treated with SU11248 (40 mg/kg/daily) and radiation (15 Gy/single-dose) had a relatively greater reduction in tumour growth, bone osteolysis, osteoclast maturation and microvessel density. Combined modality treatment resulted in improvements in behavioural pain assessment scores and normalisation of neurochemical changes in the spinal cord receiving primary afferent innervation from tumour-bearing femora. Our study demonstrates that SU11248 enhances the radiation control of metastatic breast tumours in bone and tumour-induced pain.


Assuntos
Inibidores da Angiogênese/uso terapêutico , Antineoplásicos/uso terapêutico , Neoplasias Ósseas/radioterapia , Neoplasias da Mama , Indóis/uso terapêutico , Pirróis/uso terapêutico , Radiossensibilizantes/uso terapêutico , Animais , Apoptose/efeitos dos fármacos , Neoplasias Ósseas/irrigação sanguínea , Neoplasias Ósseas/secundário , Caspases/fisiologia , Linhagem Celular Tumoral , Ensaio de Imunoadsorção Enzimática , Feminino , Camundongos , Camundongos SCID , Microcirculação , Dor/etiologia , Dor/prevenção & controle , Sunitinibe , Carga Tumoral
4.
Invest New Drugs ; 26(1): 13-24, 2008 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17805485

RESUMO

Radiation therapy is a widely used treatment for metastatic bone cancer, but the rapid onset of tumor radioresistance is a major problem. We investigated the radiosensitizing effect of enzastaurin, a protein kinase Cbeta (PKCbeta) inhibitor, on bone tumor growth and tumor-related pain. We found that enzastaurin enhanced the effect of ionizing radiation on cultured murine 4T1 breast cancer and murine endothelial cells, suppressing their proliferation and colony formation. Enzastaurin and ionizing radiation also induced caspase-mediated apoptosis of 4T1 cells to a greater degree than radiation alone. Enzastaurin treatment of 4T1 cells blocked the phosphorylation of PKCbeta, as well as Ras and two of its downstream effectors ERK1/2 and RAL-GTP. Using an orthotopic model of bone metastasis, we observed that a combination of enzastaurin and localized radiation treatment reduced tumor blood vessel density, bone destruction and pain compared to single modality treatment. In conclusion, we demonstrate that inhibition of PKCbeta in combination with localized radiation treatment suppresses tumor growth and alleviates pain as compared to radiation-only treatment. We also show that the radiosensitizing effect of enzastaurin is associated with suppression of tumor cell proliferation and tumor-induced angiogenesis possibly through inhibition of the Ras pathway.


Assuntos
Indóis/farmacologia , Neoplasias Mamárias Experimentais/tratamento farmacológico , Neoplasias Mamárias Experimentais/radioterapia , Proteína Quinase C/antagonistas & inibidores , Radiossensibilizantes/farmacologia , Animais , Apoptose/efeitos dos fármacos , Apoptose/efeitos da radiação , Neoplasias Ósseas/tratamento farmacológico , Neoplasias Ósseas/radioterapia , Neoplasias Ósseas/secundário , Caspases/metabolismo , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Sobrevivência Celular/efeitos da radiação , Terapia Combinada , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Células Endoteliais/efeitos dos fármacos , Células Endoteliais/efeitos da radiação , Feminino , Indóis/uso terapêutico , Neoplasias Mamárias Experimentais/patologia , Camundongos , Camundongos Endogâmicos C3H , Camundongos SCID , Neovascularização Patológica/tratamento farmacológico , Neovascularização Patológica/radioterapia , Osteoclastos/efeitos dos fármacos , Osteoclastos/metabolismo , Osteoclastos/efeitos da radiação , Dor/tratamento farmacológico , Dor/radioterapia , Proteína Quinase C beta , Radiossensibilizantes/uso terapêutico , Radioterapia Adjuvante/métodos , Transdução de Sinais/efeitos dos fármacos , Carga Tumoral/efeitos dos fármacos , Carga Tumoral/efeitos da radiação , Proteínas ras/metabolismo
5.
Pain ; 136(3): 293-304, 2008 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17766043

RESUMO

Although pain was previously not considered an important element of multiple sclerosis (MS), recent evidence indicates that over 50% of MS patients suffer from chronic pain. In the present study, we utilized the Theiler's murine encephalomyelitis virus (TMEV) model of MS to examine whether changes in nociception occur during disease progression and to investigate whether sex influences the development of nociception or disease-associated neurological symptoms. Using the rotarod assay, TMEV infected male mice displayed increased neurological deficits when compared to TMEV infected female mice, which mimics what is observed in human MS. While both male and female TMEV infected mice exhibited thermal hyperalgesia and mechanical allodynia, female mice developed mechanical allodynia at a faster rate and displayed significantly more mechanical allodynia than male mice. Since neuropathic symptoms have been described in MS patients, we quantified sensory nerve fibers in the epidermis of TMEV-infected and non-infected mice to determine if there were alterations in epidermal nerve density. There was a significantly higher density of PGP9.5 and CGRP-immunoreactive axons in the epidermis of TMEV-infected mice versus controls. Collectively these results indicate that the TMEV model is well suited to study the mechanisms of MS-induced nociception and suggest that alterations in peripheral nerve innervation may contribute to MS pain.


Assuntos
Infecções por Cardiovirus/fisiopatologia , Hiperalgesia/fisiopatologia , Esclerose Múltipla/fisiopatologia , Dor/fisiopatologia , Nervos Periféricos/fisiopatologia , Theilovirus , Animais , Modelos Animais de Doenças , Feminino , Masculino , Camundongos , Teste de Desempenho do Rota-Rod , Fatores Sexuais
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA